CAR-T Cell–Mediated B Cell Depletion in Central Nervous System Autoimmunity

Scientists tested anti-CD19 CAR-T cells in a B cell–dependent experimental autoimmune encephalomyelitis model that was responsive to anti-CD20 B-cell depletion similar to the clinical benefit of anti-CD20 monoclonal antibody treatment in multiple sclerosis.